Early B-Cell Activation after West Nile Virus Infection Requires Alpha/Beta Interferon but Not Antigen Receptor Signaling
about
Systems analysis of West Nile virus infectionAge-Dependent Cell Trafficking Defects in Draining Lymph Nodes Impair Adaptive Immunity and Control of West Nile Virus InfectionOpposing roles for interferon regulatory factor-3 (IRF-3) and type I interferon signaling during plagueIL-10 Signaling Blockade Controls Murine West Nile Virus InfectionProgress on the development of therapeutics against West Nile virusIPS-1 Is Essential for the Control of West Nile Virus Infection and ImmunityType I interferons in infectious diseaseA single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesisChemokine Receptor Ccr7 Restricts Fatal West Nile Virus EncephalitisRotavirus structural proteins and dsRNA are required for the human primary plasmacytoid dendritic cell IFNalpha responseA novel T-cell receptor mimic defines dendritic cells that present an immunodominant West Nile virus epitope in mice.Intracellular innate immune cascades and interferon defenses that control hepatitis C virusInterferon regulatory factor 5-dependent immune responses in the draining lymph node protect against West Nile virus infection.Impaired virus clearance, compromised immune response and increased mortality in type 2 diabetic mice infected with West Nile virus.Deficient IFN signaling by myeloid cells leads to MAVS-dependent virus-induced sepsis.Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms.A temporal role of type I interferon signaling in CD8+ T cell maturation during acute West Nile virus infection.Intrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signaling.Induction of virus-specific effector immune cell response limits virus replication and severe disease in mice infected with non-lethal West Nile virus Eg101 strain.Experimental West Nile Virus Infection in Rabbits: An Alternative Model for Studying Induction of Disease and Virus Control.From optical bench to cageside: intravital microscopy on the long road to rational vaccine design.Differential Roles of Chemokines CCL2 and CCL7 in Monocytosis and Leukocyte Migration during West Nile Virus Infection.Cell-intrinsic innate immune control of West Nile virus infection.Phenotypic characterisation of cell populations in the brains of horses experimentally infected with West Nile virus.An attenuating mutation in a neurovirulent Sindbis virus strain interacts with the IPS-1 signaling pathway in vivoA systems biology approach reveals that tissue tropism to West Nile virus is regulated by antiviral genes and innate immune cellular processesType I interferons in viral control and immune regulationPlasmacytoid dendritic cells promote rotavirus-induced human and murine B cell responses.Virally-induced upregulation of heparan sulfate on B cells via the action of type I IFN.Estimating biologically relevant parameters under uncertainty for experimental within-host murine West Nile virus infection.TLR3- and MyD88-dependent signaling differentially influences the development of West Nile virus-specific B cell responses in mice following immunization with RepliVAX WN, a single-cycle flavivirus vaccine candidateReconstituted B cell receptor signaling reveals carbohydrate-dependent mode of activation.B cell response and mechanisms of antibody protection to West Nile virus.Immune responses to West Nile virus infection in the central nervous system.West Nile virus infection and immunity.The innate immune playbook for restricting West Nile virus infection.The role of lymph node sinus macrophages in host defense.Chemokine receptors as important regulators of pathogenesis during arboviral encephalitisSubcapsular sinus macrophages limit dissemination of West Nile virus particles after inoculation but are not essential for the development of West Nile virus-specific T cell responses.Development time of IgG antibodies to West Nile virus.
P2860
Q27012977-38A552A5-8D59-460B-A2AB-428DF07A5835Q27318656-33FE9E6C-065D-42EE-B7D3-1057BE099624Q27343051-0A42C812-F755-4CAE-AA6C-2850B4BCA46FQ27489722-3785CDA5-D6FB-4181-B7D8-9636B3257C4CQ27489893-10311695-D075-476A-8AA9-C3F59736E9A9Q27490889-BDD213B0-A88D-496F-A4A0-90D9C8CC38EEQ28255842-BC3BCF53-8B4D-4FAF-82DD-01DE316D4E56Q28804076-A1C7C5E2-BBDE-4ECC-B6A3-AEAB0B61FA21Q29198018-07D13F4F-AFAC-47A8-A2D3-9F9979181818Q33598425-E5ED6324-759C-4B3D-8C69-978BBD516B80Q33934227-4DBB7735-C704-4573-AEC4-F35B4D3B5FE5Q34208090-2A32A6CA-0350-4022-A1CA-2C4894B892B5Q34261880-9535E9D0-2E49-418A-8D80-EE51447E8FB8Q34406807-B9CCC610-85B5-4AFA-A8E0-F738BF11FE02Q35152251-4A1383E4-8784-4F71-821B-B7B6032832DEQ35531167-17F1266B-3B18-4BB3-8E56-7C772145C129Q35586915-46D105A5-EA57-469C-B028-3DB2AB59B5A9Q35742553-6BCE8412-E9E1-49DC-AD21-350110F65FB7Q36081725-8FAC6447-124D-4741-B57B-D463FC03DF18Q36096374-25EC21A7-1DA1-46D2-855A-CDDE8338243BQ36108239-A12625BF-6BE5-4D29-968E-A44F448D6F2CQ36177011-7D0FDBE7-D008-4D77-A7B8-024E12C2F20DQ36287746-D918D7F3-FEDA-40CF-A6B4-D15643AF7531Q36362733-4BAC516C-245D-4502-B4A2-D744F8A5B175Q36501695-CBC5EC26-A6E9-45E0-B8CE-093DB0411E73Q36594860-7180B9B0-08CF-47FF-B1AB-51151C55A828Q36767643-B86C82E5-043E-49A7-92AF-DB51997B3F80Q36891029-2BA4E060-E47A-42C8-A49B-B3CF3AC11B25Q36916401-7301AACA-6269-4576-AEA9-90F271C3A211Q36921042-1B21ED10-FAE5-484B-901D-1C89E25773DAQ37254256-C535A906-3737-46C6-BEA7-7A49B6A1ECC3Q37380010-E911585D-261C-412B-AD62-2BDB3C5BA19CQ37673123-684128AF-EC77-4E2B-A4CE-9E5E3D8DF87CQ38068093-63D215F1-9B94-49A9-AB6B-4095E8B28335Q38074266-CB9DEEB8-EEEC-4BC5-A8D3-9FEB49ACE073Q38157732-21B758BD-C085-4C75-86B1-8D9A7AC66D16Q38193162-8DDF2FE1-8861-4E1B-85E0-0CF25D923640Q38261006-50DE8C2F-EB02-4181-8363-D179A24D7E07Q40218664-5E973D2F-63B5-4139-8B8A-169B901ED30CQ40325458-E336A178-63F3-4253-B302-D997CFEE6ADF
P2860
Early B-Cell Activation after West Nile Virus Infection Requires Alpha/Beta Interferon but Not Antigen Receptor Signaling
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Early B-Cell Activation after ...... Not Antigen Receptor Signaling
@ast
Early B-Cell Activation after ...... Not Antigen Receptor Signaling
@en
Early B-Cell Activation after ...... Not Antigen Receptor Signaling
@nl
type
label
Early B-Cell Activation after ...... Not Antigen Receptor Signaling
@ast
Early B-Cell Activation after ...... Not Antigen Receptor Signaling
@en
Early B-Cell Activation after ...... Not Antigen Receptor Signaling
@nl
prefLabel
Early B-Cell Activation after ...... Not Antigen Receptor Signaling
@ast
Early B-Cell Activation after ...... Not Antigen Receptor Signaling
@en
Early B-Cell Activation after ...... Not Antigen Receptor Signaling
@nl
P2860
P3181
P356
P1433
P1476
Early B-Cell Activation after ...... Not Antigen Receptor Signaling
@en
P2093
Karen A Chachu
Whitney E Purtha
P2860
P304
P3181
P356
10.1128/JVI.01646-08
P577
2008-11-01T00:00:00Z